• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰老内皮细胞对可生物降解支架降解的反应导致内膜功能障碍,加速支架内再狭窄。

Senescent endothelial cells' response to the degradation of bioresorbable scaffold induces intimal dysfunction accelerating in-stent restenosis.

机构信息

Key Laboratory of Biorheological and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Modern Life Science Experiment Teaching Center, Bioengineering College of Chongqing University, Chongqing 400030, PR China.

State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.

出版信息

Acta Biomater. 2023 Aug;166:266-277. doi: 10.1016/j.actbio.2023.05.028. Epub 2023 May 19.

DOI:10.1016/j.actbio.2023.05.028
PMID:37211308
Abstract

Atherosclerotic cardiovascular disease is a typical age-related disease accompanied by stiffening arteries. We aimed to elucidate the influence of aged arteries on in-stent restenosis (ISR) after the implantation of bioresorbable scaffolds (BRS). Histology and optical coherence tomography showed increased lumen loss and ISR in the aged abdominal aorta of Sprague-Dawley rats, with apparent scaffold degradation and deformation, which induce lower wall shear stress (WSS). This was also the case at the distal end of BRS, where the scaffolds degraded faster, and significant lumen loss was followed by a lower WSS. In addition, early thrombosis, inflammation, and delayed re-endothelialization were presented in the aged arteries. Degradation of BRS causes more senescent cells in the aged vasculature, increasing endothelial cell dysfunction and the risk of ISR. Thus, profoundly understanding the mechanism between BRS and senescent cells may give a meaningful guide for the age-related scaffold design. STATEMENT OF SIGNIFICANCE: The degradation of bioresorbable scaffolds aggravates senescent endothelial cells and a much lower wall shear stress areas in the aged vasculature, lead to intimal dysfunction and increasing in-stent restenosis risk. Early thrombosis and inflammation, as well as delayed re-endothelialization, are presented in the aged vasculature after bioresorbable scaffolds implantation. Age stratification during the clinical evaluation and senolytics in the design of new bioresorbable scaffolds should be considered, especially for old patients.

摘要

动脉粥样硬化性心血管疾病是一种典型的与年龄相关的疾病,伴有动脉僵硬。我们旨在阐明生物可吸收支架(BRS)植入后老年动脉对支架内再狭窄(ISR)的影响。组织学和光相干断层扫描显示,Sprague-Dawley 大鼠腹主动脉老化后管腔损失和 ISR 增加,支架明显降解和变形,导致壁面切应力(WSS)降低。在 BRS 的远端也是如此,支架降解更快,随后出现明显的管腔损失和较低的 WSS。此外,在老年动脉中还出现了早期血栓形成、炎症和延迟再内皮化。BRS 的降解导致老年血管中更多的衰老细胞,增加内皮细胞功能障碍和 ISR 的风险。因此,深入了解 BRS 和衰老细胞之间的机制可能为与年龄相关的支架设计提供有意义的指导。

意义声明

生物可吸收支架的降解加剧了衰老的内皮细胞和老年血管中更低的壁面切应力区,导致内膜功能障碍和支架内再狭窄风险增加。生物可吸收支架植入后,老年血管中出现早期血栓形成和炎症,以及延迟再内皮化。在临床评估中进行年龄分层和在新的生物可吸收支架设计中使用衰老细胞抑制剂都应该被考虑,尤其是对于老年患者。

相似文献

1
Senescent endothelial cells' response to the degradation of bioresorbable scaffold induces intimal dysfunction accelerating in-stent restenosis.衰老内皮细胞对可生物降解支架降解的反应导致内膜功能障碍,加速支架内再狭窄。
Acta Biomater. 2023 Aug;166:266-277. doi: 10.1016/j.actbio.2023.05.028. Epub 2023 May 19.
2
Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.经皮冠状动脉介入治疗后的边缘血管反应:血管内超声和光学相干断层成像评估——从放射性平台到第一代和第二代药物洗脱支架和生物可吸收支架。
JACC Cardiovasc Interv. 2013 Mar;6(3):211-21. doi: 10.1016/j.jcin.2013.01.132.
3
Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.药物洗脱生物可吸收支架与药物洗脱金属支架在直接经皮冠状动脉介入治疗后后扩张的效果:TROFI II 血管造影和光学相干断层成像亚研究。
JACC Cardiovasc Interv. 2017 Sep 25;10(18):1867-1877. doi: 10.1016/j.jcin.2017.07.035.
4
Bioresorbable scaffolds for the treatment of in-stent restenosis.用于治疗支架内再狭窄的生物可吸收支架。
Heart Vessels. 2015 Mar;30(2):265-9. doi: 10.1007/s00380-013-0464-5. Epub 2014 Jan 4.
5
Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.随机比较 Absorb 生物可吸收血管支架和 Mirage 微纤维西罗莫司洗脱支架的多模式影像学研究。
JACC Cardiovasc Interv. 2017 Jun 12;10(11):1115-1130. doi: 10.1016/j.jcin.2017.03.015. Epub 2017 May 17.
6
Treatment of In-Stent Restenosis Using Excimer Laser Coronary Atherectomy and Bioresorbable Vascular Scaffold Guided by Optical Coherence Tomography.在光学相干断层扫描引导下使用准分子激光冠状动脉斑块切除术和生物可吸收血管支架治疗支架内再狭窄
Cardiovasc Revasc Med. 2021 Jan;22:44-49. doi: 10.1016/j.carrev.2020.05.006. Epub 2020 May 14.
7
Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment of In-Stent Restenosis.生物可吸收血管支架治疗支架内再狭窄后的复发性新动脉粥样硬化
JACC Cardiovasc Interv. 2015 Aug 17;8(9):1264-1265. doi: 10.1016/j.jcin.2015.03.031.
8
Bioresorbable Vascular Scaffolds for Patients With In-Stent Restenosis: The RIBS VI Study.生物可吸收血管支架治疗支架内再狭窄患者:RIBS VI 研究。
JACC Cardiovasc Interv. 2017 Sep 25;10(18):1841-1851. doi: 10.1016/j.jcin.2017.06.064. Epub 2017 Aug 30.
9
Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold.玛格瑞斯镁可吸收支架首例临床应用的系列有创影像学随访。
Catheter Cardiovasc Interv. 2020 Feb;95(2):226-231. doi: 10.1002/ccd.28304. Epub 2019 Apr 29.
10
Very Late Restenosis Following Bioresorbable Scaffold Implantation.生物可吸收支架植入术后的极晚期再狭窄
JACC Cardiovasc Interv. 2017 Sep 25;10(18):e167-e169. doi: 10.1016/j.jcin.2017.06.015. Epub 2017 Aug 30.

引用本文的文献

1
Influence of Stent Structure on Mechanical and Degradation Properties of Poly (Lactic Acid) Vascular Stent.支架结构对聚乳酸血管支架力学性能及降解性能的影响
J Funct Biomater. 2025 Jul 6;16(7):248. doi: 10.3390/jfb16070248.
2
Impact of Arterial Stiffness on In-Stent Restenosis in the Era of Drug-Eluting Stents.药物洗脱支架时代动脉僵硬度对支架内再狭窄的影响
Rev Cardiovasc Med. 2025 Jun 19;26(6):23847. doi: 10.31083/RCM23847. eCollection 2025 Jun.
3
Stent match of pipeline embolization device: prediction of incomplete occlusion and in-stent stenosis by actual stent size after implantation.
管道栓塞装置的支架匹配:植入后根据实际支架尺寸预测不完全闭塞和支架内狭窄
Neurosurg Rev. 2025 May 30;48(1):462. doi: 10.1007/s10143-025-03625-8.
4
Impact of plant-derived antioxidants on heart aging: a mechanistic outlook.植物源抗氧化剂对心脏衰老的影响:机制展望
Front Pharmacol. 2025 Mar 21;16:1524584. doi: 10.3389/fphar.2025.1524584. eCollection 2025.
5
The influence of age on the biological response to biodegradable zinc arterial implants.年龄对可生物降解锌动脉植入物生物学反应的影响。
Materialia (Oxf). 2024 Aug;36. doi: 10.1016/j.mtla.2024.102174. Epub 2024 Jul 16.
6
Systematic Review of Interleukin-35 in Endothelial Dysfunction: A New Target for Therapeutic Intervention.内皮功能障碍中白细胞介素-35的系统评价:治疗干预的新靶点
Mediators Inflamm. 2025 Feb 12;2025:2003124. doi: 10.1155/mi/2003124. eCollection 2025.
7
Elucidating the Relationship between Neutrophil-Lymphocyte Ratio and Plaque Composition in Patients with Drug-Eluting Stent Restenosis by Virtual Histology-Intravascular Ultrasound.通过虚拟组织学血管内超声阐明药物洗脱支架再狭窄患者中性粒细胞与淋巴细胞比值与斑块成分之间的关系。
J Cardiovasc Dev Dis. 2024 Jul 4;11(7):211. doi: 10.3390/jcdd11070211.
8
A risk score for predicting in-stent restenosis in patients with premature acute myocardial infarction undergoing percutaneous coronary intervention with drug-eluting stent.预测接受药物洗脱支架经皮冠状动脉介入治疗的早发急性心肌梗死患者支架内再狭窄的风险评分。
Heliyon. 2024 Jul 4;10(13):e34077. doi: 10.1016/j.heliyon.2024.e34077. eCollection 2024 Jul 15.
9
Role of C/EBP Homologous Protein in Vascular Stenosis After Carotid Artery Injury.C/EBP 同源蛋白在颈动脉损伤后血管狭窄中的作用
Biochem Genet. 2025 Feb;63(1):832-849. doi: 10.1007/s10528-024-10713-9. Epub 2024 Mar 25.